Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Agnieszka M. Mazurek"'
Autor:
Marek Kentnowski, Alexander J. Cortez, Agnieszka M. Mazurek, Jolanta Mrochem-Kwarciak, Anna Hebda, Urszula Kacorzyk, Katarzyna Drosik-Rutowicz, Ewa Chmielik, Piotr Paul, Karolina Gajda, Izabela Łasińska, Barbara Bobek‑Billewicz, Andrea d’Amico, Krzysztof Składowski, Mirosław Śnietura, Daniel L. Faden, Tomasz W. Rutkowski
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Circulating tumor HPV DNA (ctHPV16) assessed in liquid biopsy may be used as a marker of cancer in patients with HPV-associated oropharyngeal cancer (HPV + OPC). Factors influencing the initial ctHPV16 quantity are not well recognized. In th
Externí odkaz:
https://doaj.org/article/dcfecdbf57b84806b009bf01d9b989a6
Autor:
Tomasz W. Rutkowski, Agnieszka M. Mazurek, Mirosław Śnietura, Beata Hejduk, Maja Jędrzejewska, Barbara Bobek-Billewicz, Andrea d’Amico, Wojciech Pigłowski, Andrzej Wygoda, Krzysztof Składowski, Zofia Kołosza, Piotr Widłak
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Early detection of treatment failure may improve clinical outcome and overall survival in patients with head and neck cancer after first-line treatment. Circulating cell-free HPV16 DNA (cfHPV16 DNA) was evaluated as a possible com
Externí odkaz:
https://doaj.org/article/9aed613baac3455ebd00a4bcbc94a734
Autor:
Agnieszka M. Mazurek, Ewa Małusecka, Iwona Jabłońska, Natalia Vydra, Tomasz W. Rutkowski, Monika Giglok, Rafał Suwiński
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 867
Volume 15
Issue 3
Pages: 867
Background: Implementation of anal squamous cell carcinoma (ASCC) treatment modifications requires reliable patient risk stratification. The circulating tumor–related human papillomavirus type 16 (ctHPV16) may play a role in predicting survival or
Autor:
Tomasz Rutkowski, Ewa Chmielik, Ewa Małusecka, Monika Giglok, Rafał Suwiński, Dariusz Lange, Agnieszka M. Mazurek
Publikováno v:
Pathology Oncology Research
Human papilloma virus (HPV) is highly frequent among patients with anal squamous cell carcinoma, but the viral load (VL) differs between patients. This study aimed to compare the rate of HPV positivity, HPV16VL, p16INK4A and p53 expression between tr
Autor:
Beata Jabłońska, Tomasz Rutkowski, Marek Kentnowski, Zofia Kołosza, Adam Brewczyński, Jolanta Mrochem-Kwarciak, Krzysztof Składowski, Agnieszka M. Mazurek, Sławomir Mrowiec, Mirosław Śnietura
Publikováno v:
Cancers, Vol 13, Iss 3256, p 3256 (2021)
Cancers
Volume 13
Issue 13
Cancers
Volume 13
Issue 13
Several immune and hematological parameters are associated with survival in patients with oropharyngeal cancer (OPC). The aim of the study was to analyze selected immune and hematological parameters of patients with HPV-related (HPV+) and HPV-unrelat
Autor:
Tomasz Rutkowski, Andrzej Wygoda, Magdalena Olbryt, Monika Pietrowska, Agnieszka M. Mazurek, Agata Celejewska, Krzysztof Składowski, Piotr Widlak
Publikováno v:
Journal of Medical Virology. 92:348-355
Nasopharyngeal cancer (NPC) is highly prevalent in southern Chinese populations but it is rare in most parts of the world. A few studies were performed in nonendemic regions of the world, and suggested the prognostic value of Epstein-Barr virus (EBV)
Autor:
Agnieszka M. Mazurek, Piotr Widlak, Zofia Kołosza, Barbara Bobek-Billewicz, Andrzej Wygoda, Maja Jędrzejewska, B. Hejduk, Wojciech Piglowski, Tomasz Rutkowski, Andrea D’Amico, Krzysztof Składowski, Mirosław Śnietura
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Journal of Translational Medicine
Journal of Translational Medicine
Background Early detection of treatment failure may improve clinical outcome and overall survival in patients with head and neck cancer after first-line treatment. Circulating cell-free HPV16 DNA (cfHPV16 DNA) was evaluated as a possible complementar
Autor:
Regina Deja, Agnieszka M. Mazurek, Andrzej Wygoda, Jolanta Mrochem-Kwarciak, Tomasz Rutkowski, Krzysztof Składowski, Aleksandra Chmura
Publikováno v:
Oral Oncology. 118:5
Publikováno v:
Cancer Biomarkers. 15:515-524
BACKGROUND: Analysis of circulating cell-free DNA in blood is considered as a liquid biopsy, which enables non-invasive and repetitive investigation of the tumor DNA. The potential clinical usefulness of circulating DNA is frequently examined in lung
Autor:
G Głowacki, Anna Fiszer-Kierzkowska, Krzysztof Składowski, Tomasz Rutkowski, Dorota Scieglinska, G Woźniak, Ewa Małusecka, R Kawczyński, Agnieszka M. Mazurek, M Pierzyna
Publikováno v:
Cancer Biomarkers. 13:385-394
Background The precise analysis of tumour markers in blood such as circulating cell-free DNA (cfDNA) could have a significant impact in facilitating monitoring of patients after initial therapy. Although high levels of total cfDNA in plasma of cancer